ID   TK-164
AC   CVCL_8324
SY   TK 164; TK164
DR   BTO; BTO:0004284
DR   Cosmic; 845928
DR   Wikidata; Q54972525
RX   PubMed=3594443;
RX   PubMed=27993170;
CC   Doubling time: 43 hours (PubMed=3594443).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=3594443;
RA   Bear A., Clayman R.V., Elbers J., Limas C., Wang N., Stone K.,
RA   Gebhard R., Prigge W., Palmer J.;
RT   "Characterization of two human cell lines (TK-10, TK-164) of renal
RT   cell cancer.";
RL   Cancer Res. 47:3856-3862(1987).
//
RX   PubMed=27993170; DOI=10.1186/s12943-016-0565-8;
RA   Brodaczewska K.K., Szczylik C., Fiedorowicz M., Porta C.,
RA   Czarnecka A.M.;
RT   "Choosing the right cell line for renal cell cancer research.";
RL   Mol. Cancer 15:83.1-83.15(2016).
//